Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $110.78 million. The enterprise value is $159.57 million.
| Market Cap | 110.78M |
| Enterprise Value | 159.57M |
Important Dates
The last earnings date was Friday, May 9, 2025, before market open.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.63 million shares outstanding. The number of shares has increased by 2.97% in one year.
| Current Share Class | 16.63M |
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | +2.97% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 36.23% |
| Owned by Institutions (%) | 39.34% |
| Float | 10.61M |
Valuation Ratios
The trailing PE ratio is 21.39 and the forward PE ratio is 8.43.
| PE Ratio | 21.39 |
| Forward PE | 8.43 |
| PS Ratio | 0.64 |
| Forward PS | 0.65 |
| PB Ratio | 0.81 |
| P/TBV Ratio | 1.65 |
| P/FCF Ratio | 6.28 |
| P/OCF Ratio | 5.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.37, with an EV/FCF ratio of 9.05.
| EV / Earnings | 30.19 |
| EV / Sales | 0.92 |
| EV / EBITDA | 11.37 |
| EV / EBIT | 16.82 |
| EV / FCF | 9.05 |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.42.
| Current Ratio | 3.22 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | 3.26 |
| Interest Coverage | 3.87 |
Financial Efficiency
Return on equity (ROE) is 4.05% and return on invested capital (ROIC) is 3.38%.
| Return on Equity (ROE) | 4.05% |
| Return on Assets (ROA) | 2.93% |
| Return on Invested Capital (ROIC) | 3.38% |
| Return on Capital Employed (ROCE) | 4.93% |
| Revenue Per Employee | $258,234 |
| Profits Per Employee | $7,878 |
| Employee Count | 671 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, Ultralife has paid $1.76 million in taxes.
| Income Tax | 1.76M |
| Effective Tax Rate | 24.59% |
Stock Price Statistics
The stock price has decreased by -44.78% in the last 52 weeks. The beta is 0.77, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -44.78% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 7.41 |
| Relative Strength Index (RSI) | 72.08 |
| Average Volume (20 Days) | 76,507 |
Short Selling Information
The latest short interest is 313,638, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 313,638 |
| Short Previous Month | 284,922 |
| Short % of Shares Out | 1.89% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, Ultralife had revenue of $173.28 million and earned $5.29 million in profits. Earnings per share was $0.31.
| Revenue | 173.28M |
| Gross Profit | 43.65M |
| Operating Income | 9.49M |
| Pretax Income | 12.33M |
| Net Income | 5.29M |
| EBITDA | 14.03M |
| EBIT | 9.49M |
| Earnings Per Share (EPS) | $0.31 |
Balance Sheet
The company has $8.72 million in cash and $57.51 million in debt, giving a net cash position of -$48.79 million or -$2.93 per share.
| Cash & Cash Equivalents | 8.72M |
| Total Debt | 57.51M |
| Net Cash | -48.79M |
| Net Cash Per Share | -$2.93 |
| Equity (Book Value) | 136.60M |
| Book Value Per Share | 8.20 |
| Working Capital | 69.97M |
Cash Flow
In the last 12 months, operating cash flow was $20.09 million and capital expenditures -$2.46 million, giving a free cash flow of $17.63 million.
| Operating Cash Flow | 20.09M |
| Capital Expenditures | -2.46M |
| Free Cash Flow | 17.63M |
| FCF Per Share | $1.06 |
Margins
Gross margin is 25.19%, with operating and profit margins of 5.47% and 3.05%.
| Gross Margin | 25.19% |
| Operating Margin | 5.47% |
| Pretax Margin | 4.12% |
| Profit Margin | 3.05% |
| EBITDA Margin | 8.10% |
| EBIT Margin | 5.47% |
| FCF Margin | 10.17% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.97% |
| Shareholder Yield | -2.97% |
| Earnings Yield | 4.77% |
| FCF Yield | 15.92% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 110.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 110.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 2.12 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 4 |